Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation

scientific article published on December 1998

Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID9845522

P50authorPer LjungmanQ52717443
P2093author name stringRemberger M
Ringdén O
Lönnqvist B
Klaesson S
Hägglund H
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectrisk factorQ1475848
P304page(s)4568-4572
P577publication date1998-12-01
P1433published inBloodQ885070
P1476titleNorethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation
P478volume92

Reverse relations

cites work (P2860)
Q53941832Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells.
Q35671371Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management
Q35029393Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Prophylaxis and treatment controversies.
Q34479575Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome
Q37783608Hepatic veno-occlusive disease: a chemotherapy-related toxicity in children with malignancies
Q34099434Hepatic venous outflow obstruction: three similar syndromes
Q37073000Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.
Q28083417Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
Q73292481Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide
Q48165128Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
Q58034430Vascular disorders of the liver

Search more.